The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation

NCT05420012 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions

DRUG: Vericiguat
DRUG: Placebo

Sponsor

Josef Stehlik

Collaborators

[object Object]